Celldex Therapeutics Inc

NEW
NAS:CLDX (USA)  
$ 38.31 +0.14 (+0.37%) 04:00 PM EST
At Loss
P/B:
5.59
Market Cap:
$ 3.01B
Enterprise V:
$ 2.56B
Volume:
533.42K
Avg Vol (2M):
1.05M
Trade In:
Volume:
533.42K
At Loss
Avg Vol (2M):
1.05M

Celldex Therapeutics Inc Stock Institutional Ownership and Insider Ownership -

78.49
(Mil)
Shares Outstanding
98.39%
77.22 (Mil)
Institutional Ownership
8.52%
6.68 (Mil)
Insider Ownership
84.25%
66.1307 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Celldex Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Celldex Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders